Human Cytomegalovirus (HCMV) IE1 Plays Role in Resistance to Apoptosis with Etoposide in Cancer Cell Line by Cdk2 Accumulation

Microbiology and Immunology

Volumn 47, Issue 12, 2003, Pages 959-967

  Kim, Jinhee ^a   Kwon, Ye Jin ^a   Park, Eun Suk ^a   Sung, Bohyun ^a   Kim, Jung Heon ^a   Park, Chung Gyu ^a   Hwang, Eung Soo ^a   Cha, Chang Yong ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cyclin dependent kinase 2; Drug resistance; Etoposide; Human cytomegalovirus (HCMV); Immediate early protein (IE)

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 2; CASPASE 3; CYCLIN DEPENDENT KINASE 2; ETOPOSIDE; GENE PRODUCT; HUMAN CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEIN 1; IMMEDIATE EARLY PROTEIN; ROSCOVITINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL PROTECTION; DRUG ACCUMULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENETIC SUSCEPTIBILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; TARGET CELL; TUMOR GROWTH;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0346734227     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03470.x     Document Type: Article

References (52)

1. Afonso, C.L., Neilan, J.G., Kutish, G.F., and Rock, D.L. 1996. An African swine fever virus Bcl-2 homolog, 5-HL, suppresses apoptotic cell death. J. Virol. 70: 4858-4863.
2. Alessi, F., Quarta, S., Savio, M., Riva, F., Rossi, L., Stivala, L.A., Scovassi, A.I., Meijer, L., and Prosperi, E. 1998. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell Res. 245: 8-18.
3. Bresnahan, W.A., Boldogh, I., Chi, P., Thompson, E.A., and Albrecht, T. 1997. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231: 239-247.
4. Bresnahan, W.A., Thompson, E.A., and Albrecht, T. 1997. Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J. Gen. Virol. 78: 1993-1997.
5. Buckley, C.D., Pilling, D., Henriquez, N.V., Parsonage, G., Threlfall, K., Scheel-Toellner, D., Simmons, D.L., Akbar, A.N., Lord, J.M., and Salmon, M. 1999. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397: 534-539.
6. Chen, Y.N., Sharma, S.K., Ramsey, T.M., Jiang, L., Martin, M.S., Baker, K., Adams, P.D., Bair, K.W., and Kaelin, W.G. 1999. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc. Natl. Acad. Sci. U.S.A. 96: 4325-4329.
7. Cinatl, J., Jr., Cinatl, J., Vogel, J.U., Kotchetkov, R., Driever, P.H., Kabickova, H., Kornhuber, B., Schwabe, D., and Doerr, H.W. 1998. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 58: 367-372.
8. Cinatl, J., Jr., Cinatl, J., Vogel, J.U., Rabenau, H., Kornhuber, B., and Doerr, H.W. 1996. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39: 259-269.
9. Cinatl, J., Jr., Vogel, J.U., Cinatl, J., Weber, B., Rabenau, H., Novak, M., Kornhuber, B., and Doerr, H.W. 1996. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int. J. Cancer 65: 90-96.
10. Cory, S. 1998. Cell death throes. Proc. Natl. Acad. Sci. U.S.A. 95: 12077-12079.
11. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94: 7245-7250.
12. Dive, C., Evans, C.A., and Whetton, A.D. 1992. Induction of apoptosis - new targets for cancer chemotherapy. Semin. Cancer Biol. 3: 417-427.
13. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245-2262.
14. Forbes, I.J., Zalewski, P.D., Giannakis, C., and Cowled, P.A. 1992. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198: 367-372.
15. Fraker, P.J., King, L.E., Lill-Elghanian, D., and Telford, W.G. 1995. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol. 46: 57-76.
16. Gagliardini, V., Fernandez, P.A., Lee, R.K., Drexler, H.C., Rotello, R.J., Fishman, M.C., and Yuan, J. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263: 826-828.
17. Galvan, V., Brandimarti, R., and Roizman, B. 1999. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J. Virol. 73: 3219-3226.
18. Guo, M., and Hay, B.A. 1999. Cell proliferation and apoptosis. Curr. Opin. Cell Biol. 11: 745-752.
19. Hagemeier, C., Caswell, R., Hayhurst, G., Sinclair, J., and Kouzarides, T. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13: 2897-2903.
20. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 90: 8479-8483.
21. Hengel, H., Brune, W., and Koszinowski, U.H. 1998. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol. 6: 190-197.
22. Hinshaw, V.S., Olsen, C.W., Dybdahl-Sissoko, N., and Evans, D. 1994. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68: 3667-3673.
23. Huang, E.S., Chen, S.T., and Pagano, J.S. 1973. Human cytomegalovirus. I. Purification and characterization of viral DNA. J. Virol. 12: 1473-1481.
24. Huang, E.S., and Kowalik, T.F. 1993. The pathogenicity of human cytomegalovirus: an overview, p. 3-45. In Becker, Y., Darai, G., and Huang, E. (eds), Molecular aspects of human cytomegalovirus diseases, Springer-Verlag, Berlin.
25. Johnson, R.A., Yurochko, A.D., Poma, E.E., Zhu, L., and Huang, E.S. 1999. Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences. J. Gen. Virol. 80: 1293-1303.
26. Kamiya, S., Tanaka, J., Ogura, T., Ogura, H., Sato, H., and Hatano, M. 1986. Rabbit kidney cells abortively infected with human cytomegalovirus are arrested in mitotic phase. Arch. Virol. 89: 131-144.
27. Kaufmann, S.H. 1989. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49: 5870-5878.
28. Levine, B., Huang, Q., Isaacs, J.T., Reed, J.C., Griffin, D.E., and Hardwick, J.M. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361: 739-742.
29. Liu, L.F. 1989. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58: 351-375.
30. Lock, R.B., and Stribinskiene, L. 1996. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 56: 4006-4012.
31. McCarthy, S.A., Symonds, H.S., and Van Dyke, T. 1994. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Sci. U.S.A. 91: 3979-3983.
32. Meng, R.D., Phillips, P., and El-Deiry, W.S. 1999. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int. J. Oncol. 14: 5-14.
33. Muralidhar, S., Doniger, J., Mendelson, E., Araujo, J.C., Kashanchi, F., Azumi, N., Brady, J.N., and Rosenthal, L.J. 1996. Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription. J. Virol. 70: 8691-8700.
34. Nigro, G., Schiavetti, A., Booth, J.C., Clerico, A., Dominici, C., Krzysztofiak, A., and Castello, M. 1995. Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4. Med. Pediatr. Oncol. 24: 200-203.
35. Nip, J., Strom, D.K., Fee, B.E., Zambetti, G., Cleveland, J.L., and Hiebert, S.W. 1997. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17: 1049-1056.
36. O'Hare, M.J., Hou, S.T., Morris, E.J., Cregan, S.P., Xu, Q., Slack, R.S., and Park, D.S. 2000. Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275: 25358-25364.
37. Pajovic, S., Wong, E.L., Black, A.R., and Azizkhan, J.C. 1997. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell. Biol. 17: 6459-6464.
38. Pan, H., and Griep, A.E. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8: 1285-1299.
39. Poma, E.E., Kowalik, T.F., Zhu, L., Sinclair, J.H., and Huang, E.S. 1996. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70: 7867-7877.
40. Quillet-Mary, A., Mansat, V., Duchayne, E., Come, M.G., Allouche, M., Bailly, J.D., Bordier, C., and Laurent, G. 1996. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell fines. Leukemia 10: 417-425.
41. Rosenthal, L., and Choudhury, S. 1993. Potential oncogenicity of human cytomegalovirus, p. 412-436. In Becker, Y., Darai, G., and Huang, E. (eds), Molecular aspects of human cytomegalovirus diseases, Springer-Verlag, Berlin.
42. Sen, S., and D'Incalci, M. 1992. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett. 307: 122-127.
43. Shen, Y., and Shenk, T.E. 1995. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5: 105-111.
44. Shimizu, T., Kubota, M., Tanizawa, A., Sano, H., Kasai, Y., Hashimoto, H., Akiyama, Y., and Mikawa, H. 1990. Inhibition of both etoposide-induced DNA fragmentation and activation of poly (ADP-ribose) synthesis by zinc ion. Biochem. Biophys. Res. Commun. 169: 1172-1177.
45. Sommer, M.H., Scully, A.L., and Spector, D.H. 1994. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 68: 6223-6231.
46. Speir, E., Modali, R., Huang, E.S., Leon, M.B., Shawl, F., Finkel, T., and Epstein, S.E. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394.
47. Takizawa, T., Matsukawa, S., Higuchi, Y., Nakamura, S., Nakanishi, Y., and Fukuda, R. 1993. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74: 2347-2355.
48. Teodoro, J.G., and Branton, P.E. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71: 1739-1746.
49. Thornberry, N.A., and Lazebnik, Y. 1998. Caspases: enemies within. Science 281: 1312-1316.
50. Yamasaki, L. 1999. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. Biochim. Biophys. Acta 1423: M9-15.
51. Zhu, H., Cong, J.P., Yu, D., Bresnahan, W.A., and Shenk, T.E. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 99: 3932-3937.
52. Zhu, H., Shen, Y., and Shenk T. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69: 7960-7970.